Physician

Rebecca L Danforth, M.D.

According to 2025 Medicare claims, Rebecca Danforth, M.D. (NPI: 1164570172) practices rheumatology in the Missoula, MT market, with the plurality of this provider's patient population coming from Missoula, MT. This provider's primary affiliated billing organization is WESTERN MONTANA CLINIC PC (NPI: 1942253182; TIN: 810226415) and primary practice location at 59802-4008. Danforth is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), MountainStar Care Partners ACO (ACO ID: A5181), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Danforth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 423 traditional Medicare patients, billed 56,635 HCPCS/CPT codes, and received $807,782 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,700 prescription claims across 317 beneficiaries totaling $1,833,219 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 11 claims. Open Payments data shows 34 records totaling $620. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $87,226 to $807,782. Similarly, Part D prescription costs have risen steadily, from $171,695 to $1,833,219. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$489K$978K2015 Medicare payment: $87,226 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $107,100 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $64,161 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $158,632 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $846,726 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $978,094 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $846,064 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $738,589 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $737,430 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $807,782 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152512,858$87,226
20162564,639$107,100
20172681,568$64,161
201828611,762$158,632
201933150,286$846,726
202034953,709$978,094
202134243,404$846,064
202237945,538$738,589
202338754,915$737,430
202442356,635$807,782

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$917K$1.8M2015 Drug cost: $171,695 (USD; Tot_Drug_Cst)2016 Drug cost: $249,023 (USD; Tot_Drug_Cst)2017 Drug cost: $284,622 (USD; Tot_Drug_Cst)2018 Drug cost: $246,818 (USD; Tot_Drug_Cst)2019 Drug cost: $63,682 (USD; Tot_Drug_Cst)2020 Drug cost: $47,396 (USD; Tot_Drug_Cst)2021 Drug cost: $370,275 (USD; Tot_Drug_Cst)2022 Drug cost: $760,571 (USD; Tot_Drug_Cst)2023 Drug cost: $1,059,096 (USD; Tot_Drug_Cst)2024 Drug cost: $1,833,219 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151731,522$171,695
20161941,576$249,023
20171721,522$284,622
20181701,192$246,818
2019177820$63,682
20201731,220$47,396
20212081,723$370,275
20222511,827$760,571
20232851,993$1,059,096
20243172,700$1,833,219

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$49$982015 Medicare payment: $98 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R11$98
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more116160$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more258385$86
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less90200$48
J1602Injection, golimumab, 1 mg, for intravenous use3915,174$9
36415Insertion of needle into vein for collection of blood sample58107$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab852,380$782,752
Enbrel SureclickEtanercept681,904$504,569
Orencia ClickjectAbatacept19532$106,157
ActemraTocilizumab12336$57,533
Hydroxychloroquine SulfateHydroxychloroquine Sulfate41924,968$14,199

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$620PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

Explore More Providers

FAQ

What Medicare data is available for Rebecca L. Danforth, M.D.?

Tedicare shows public-source Medicare data for Rebecca L. Danforth, M.D. (NPI 1164570172), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rebecca L. Danforth, M.D. have ACO affiliation data?

Rebecca L. Danforth, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), MountainStar Care Partners ACO (MSSP, ACO ID A5181), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rebecca L. Danforth, M.D.?

Rebecca L. Danforth, M.D. is linked to WESTERN MONTANA CLINIC PC (billing NPI 1942253182) in the available physician profile data.

Does Rebecca L. Danforth, M.D. have Open Payments data?

Rebecca L. Danforth, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.